(Reuters) - Medical device maker Covidien Plc said it was recalling 14 lots of its Monoject prefill flush syringes sold in the United States and Bermuda as they contained non-sterilized water which could cause life-threatening infections.
Some of the syringes, meant to administer saline or anti-clotting drug heparin, also had mismatched caps, labels and wrappers, the company said. (http://link.reuters.com/jag52v)
The syringes are used to reduce blood clots in veins and remove medication left at catheter sites.
Using the heparin syringe containing only water could cause clotting in catheters.